CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest
Balance, shares at Jun. 30, 2020			10,222,223
Balance, amount at Jun. 30, 2020	$ 2,179,381	$ 0	$ 10,223	$ 7,314,341	$ (7,098,984)	$ 1,953,801
Conversion of Trunano subsidiary stock into Grove common stock, shares			1,277,778
Conversion of Trunano subsidiary stock into Grove common stock, amount	0	0	$ 1,278	1,952,523	0	(1,953,801)
Issuance of common stock for acquisition of Infusionz, shares			222,223
Issuance of common stock for acquisition of Infusionz, amount	340,000	0	$ 223	339,777	0	0
Issuance of common stock for acquisition costs, shares			83,334
Issuance of common stock for acquisition costs, amount	127,500	0	$ 83	127,417	0	0
Stock based compensation	93,193	0	0	93,193	0
Net loss	$ (809,073)	0	$ 0	0	(809,073)	0
Balance, shares at Sep. 30, 2020	83,334		11,805,558
Balance, amount at Sep. 30, 2020	$ 1,931,001	$ 0	$ 11,807	9,827,251	(7,908,057)	0
Balance, shares at Jun. 30, 2021		500,000	15,262,394
Balance, amount at Jun. 30, 2021	21,217,973	$ 500	$ 15,262	25,372,247	(4,170,036)	0
Issuance of common stock for acquisition of Infusionz, shares			306,945
Issuance of common stock for acquisition of Infusionz, amount	1,764,876	0	$ 307	1,764,569	0	0
Issuance of common stock for acquisition costs, shares			7,000
Issuance of common stock for acquisition costs, amount	33,740	0	$ 7	33,733	0	0
Stock based compensation	593,098	0	0	593,098	0	0
Net loss	511,711	0	$ 0	0	511,711	0
Issuance of common stock for acquisition of VitaMedica, shares			100,000
Issuance of common stock for acquisition of VitaMedica, amount	482,000	0	$ 100	481,900	0	0
Issuance of common stock for services, shares			35,000
Issuance of common stock for services, amount	175,000	$ 0	$ 35	174,965	0	0
Balance, shares at Sep. 30, 2021		500,000	15,711,339
Balance, amount at Sep. 30, 2021	$ 24,778,398	$ 500	$ 15,711	$ 28,420,512	$ (3,658,325)	$ 0